Akums Drugs & Pharma Shareholding Pattern

Akums Drugs & Pharma shareholding pattern. As of Sept 2026, Akums Drugs & Pharma (AKUMS) promoter holding 75.26%, FII 4.50%, DII 11.08%, public 5.21%, total shareholders 67,618. See AKUMS price to book ratio to compare market price against book value per share.

Promoter Holding 75.26%

FII Holding 4.50%

DII Holding 11.08%

Public Holding 5.21%

Total Shareholders 67,618

As of Sept 2026

AKUMS Recent Shareholding Changes — Promoter, FII & DII

Akums Drugs & Pharma promoter, FII and DII holding change from Jun 2026 to Sept 2026, FII +2.59%, DII -2.36%. Browse AKUMS financial statements for revenue, profit, balance sheet and cash flow data.

Promoter Holding Change

Jun 2026 to Sept 2026

No Change

FII Holding Change

Jun 2026 to Sept 2026

+2.59%

DII Holding Change

Jun 2026 to Sept 2026

-2.36%

Public Holding Change

Jun 2026 to Sept 2026

-0.36%

Akums Drugs & Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

AKUMS promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see AKUMS screener.

Promoter

FII

DII

Public

Government

AKUMS Shareholding Pattern Data — Quarterly History

Akums Drugs & Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Sept 2026	75.26%	4.50%	11.08%	0.00%	5.21%	3.94%	99.99%	67,618
Jun 2026	75.26%	1.91%	13.44%	0.00%	5.57%	3.82%	100.00%	70,289
Mar 2026	75.26%	1.37%	14.35%	0.00%	5.34%	3.68%	100.00%	72,589
Dec 2025	75.26%	1.15%	14.40%	0.00%	5.51%	3.68%	100.00%	76,869
Sept 2025	75.26%	2.28%	9.28%	0.00%	5.01%	8.18%	100.01%	75,365
Jun 2025	75.26%	4.24%	8.85%	0.00%	3.60%	8.05%	100.00%	69,424
Mar 2025	75.26%	5.77%	7.40%	0.00%	3.41%	8.16%	100.00%	69,366
Dec 2024	75.26%	6.36%	7.00%	0.00%	3.33%	8.05%	100.00%	68,410
Sept 2024	75.26%	7.34%	7.52%	0.00%	2.11%	7.77%	100.00%	57,531
Aug 2024	75.26%	5.32%	7.60%	0.00%	4.43%	7.38%	99.99%	138,205
Feb 2024	84.91%	0.00%	0.00%	0.00%	0.00%	15.09%	100.00%	8

Quarter	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Sept 2026	75.26%	4.50%	11.08%	0.00%	5.21%	3.94%	99.99%	67,618
Jun 2026	75.26%	1.91%	13.44%	0.00%	5.57%	3.82%	100.00%	70,289
Mar 2026	75.26%	1.37%	14.35%	0.00%	5.34%	3.68%	100.00%	72,589
Dec 2025	75.26%	1.15%	14.40%	0.00%	5.51%	3.68%	100.00%	76,869
Sept 2025	75.26%	2.28%	9.28%	0.00%	5.01%	8.18%	100.01%	75,365
Jun 2025	75.26%	4.24%	8.85%	0.00%	3.60%	8.05%	100.00%	69,424
Mar 2025	75.26%	5.77%	7.40%	0.00%	3.41%	8.16%	100.00%	69,366
Dec 2024	75.26%	6.36%	7.00%	0.00%	3.33%	8.05%	100.00%	68,410
Sept 2024	75.26%	7.34%	7.52%	0.00%	2.11%	7.77%	100.00%	57,531
Aug 2024	75.26%	5.32%	7.60%	0.00%	4.43%	7.38%	99.99%	138,205
Feb 2024	84.91%	0.00%	0.00%	0.00%	0.00%	15.09%	100.00%	8

Year	Promoter (%)	FII (%)	DII (%)	Govt (%)	Public (%)	Other (%)	Total (%)	Shareholders
Mar 2026	75.26%	1.37%	14.35%	0.00%	5.34%	3.68%	100.00%	72,589
Dec 2025	75.26%	1.15%	14.40%	0.00%	5.51%	3.68%	100.00%	76,869
Dec 2024	75.26%	6.36%	7.00%	0.00%	3.33%	8.05%	100.00%	68,410